Ashish Shah, CEO, Dina – The Health Care Blog
Health Tech Dina is a tech company that helps coordinates care in the home. CEO Ashish Shah explains that their platform is used by care coordinators, social workers and others...
Health Tech Dina is a tech company that helps coordinates care in the home. CEO Ashish Shah explains that their platform is used by care coordinators, social workers and others...
Kentucky, which began its new legislative session this week, has one school bathroom bill in committee that would allow families to sue if their child encounters a trans student while...
The past 12 months have allowed the nation and our healthcare organizations to work toward achieving a new normal in terms of patient care delivery and the management of our...
I’ve noticed that most people tend to focus on only one of four variables when optimizing their digital marketing results. That’s a shame because true optimization requires a more strategic...
One of the deals responsible for self-directed care momentum in 2022 has been axed. In September, it was announced that the special acquisition purpose company (SPAC) DTRT Health Acquisition Corp....
Skip to content XAbout Rama SmartSearchRamaOnHealthcare brings signal to noise to keep you up-to-date with the latest healthcare industry news. We continuously refine our search algorithm to help you quickly and...
Community Pharmacies Rely on Automated Workflows and AI-Enabled Personalization “When you think about the medically underserved in rural areas, pharmacies are likely the only convenient access to care,” says Jason...
“Are we losing the battle against heart disease?” asks the lead article featured in the January 2023 issue of the AARP Bulletin. “Despite breathtaking medical...
CommonSpirit Health, one of the nation’s largest health systems is facing a proposed class-action lawsuit over a ransomware attack it suffered last fall. How perilous is this for a health...
An experimental Alzheimer’s drug that moderately slows cognitive decline was approved by the Food and Drug Administration (FDA) on Friday. The drug, called lecanemab, was granted conditional approval based on...